Comparative Analysis of Cost-effectiveness Between Sulfonylureas and DPP4 Inhibitors in Combination With Metformin in Treatment of Type 2 Diabetic Patients : A Retrospective, Observational Study.

NCT06570980 · clinicaltrials.gov ↗

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes Mellitus (T2DM), Cost-effectiveness, Sulfonylureas, DPP4 Inhibitors, Metformin

Interventions

DRUG: sulfonylurease with metformin, DPP4 inhibitors with Metformin

Sponsor

Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh